PMID- 16390704
OWN - NLM
STAT- MEDLINE
DCOM- 20060307
LR  - 20161124
IS  - 0144-3615 (Print)
IS  - 0144-3615 (Linking)
VI  - 26
IP  - 1
DP  - 2006 Jan
TI  - Thromboprophylaxis after vaginal delivery: a district general hospital 
      experience.
PG  - 24-6
AB  - The Confidential Enquiries into Maternal Deaths (RCOG 2001) recommends risk 
      assessment and appropriate thromboprophylaxis after vaginal delivery. This study 
      examines the risk group and the need for thromboprophylaxis after vaginal 
      delivery in our local population and the cost implications for the same. It is a 
      retrospective study of women who delivered in the month of November 2003. There 
      were 307 deliveries, of these 251 (81.7%) were vaginal deliveries. Confidential 
      Enquiries into Maternal Deaths (CEMD) risk classification was possible for 243 
      women. A total of 170 women were low risk, 66 (27.16%) moderate risk and 7 
      (2.88%) high risk. The costs of thromboprophylaxis for the year in our unit were 
      calculated as pound7,339.71 for unfractionated heparin (UFH) 5,000 IU twice daily 
      and pound7,098.27 for 40 mg enoxaparin once daily. A total of 30% of our District 
      General Hospital population were classified as moderate or high risk for 
      thromboprophylaxis after vaginal delivery. It is less expensive to use enoxaparin 
      compared with unfractionated heparin for thromboprophylaxis.
FAU - Potdar, N
AU  - Potdar N
AD  - Reproductive Sciences Section, University of Leicester, Leicester Royal 
      Infirmary, Leicester, UK. np78@le.ac.uk
FAU - Jabbar, B
AU  - Jabbar B
FAU - Burrell, S J
AU  - Burrell SJ
LA  - eng
PT  - Journal Article
PL  - England
TA  - J Obstet Gynaecol
JT  - Journal of obstetrics and gynaecology : the journal of the Institute of 
      Obstetrics and Gynaecology
JID - 8309140
RN  - 0 (Anticoagulants)
RN  - 0 (Enoxaparin)
RN  - 9005-49-6 (Heparin)
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Anticoagulants/economics/*therapeutic use
MH  - Bandages
MH  - Chemoprevention
MH  - *Delivery, Obstetric
MH  - Enoxaparin/economics/*therapeutic use
MH  - Female
MH  - Heparin/economics/*therapeutic use
MH  - Hospital Costs
MH  - Hospitals, District
MH  - Hospitals, General
MH  - Humans
MH  - Postnatal Care
MH  - Pulmonary Embolism/prevention & control
MH  - Retrospective Studies
MH  - Risk Assessment
MH  - Time Factors
MH  - United Kingdom
MH  - Venous Thrombosis/economics/*prevention & control
EDAT- 2006/01/05 09:00
MHDA- 2006/03/08 09:00
CRDT- 2006/01/05 09:00
PHST- 2006/01/05 09:00 [pubmed]
PHST- 2006/03/08 09:00 [medline]
PHST- 2006/01/05 09:00 [entrez]
AID - W617568674210527 [pii]
AID - 10.1080/01443610500363931 [doi]
PST - ppublish
SO  - J Obstet Gynaecol. 2006 Jan;26(1):24-6. doi: 10.1080/01443610500363931.